Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2d3m | COA | 5,7-dihydroxy-2-methylchromone synthase | 2.3.1.216 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2d3m | COA | 5,7-dihydroxy-2-methylchromone synthase | 2.3.1.216 | 1.000 | |
| 2d52 | COA | 5,7-dihydroxy-2-methylchromone synthase | 2.3.1.216 | 0.759 | |
| 1ee0 | CAA | 2-pyrone synthase | / | 0.596 | |
| 3wd7 | COA | Acridone synthase | / | 0.522 | |
| 3wxy | COA | Uncharacterized protein | / | 0.511 | |
| 3wy0 | COA | Uncharacterized protein | / | 0.494 | |
| 4jaq | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.493 | |
| 4jd3 | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.480 | |
| 1fnn | ADP | ORC1-type DNA replication protein | / | 0.467 | |
| 1ppj | SMA | Cytochrome b | / | 0.466 | |
| 2vnh | FAD | NADPH:ferredoxin reductase | / | 0.466 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.465 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.463 | |
| 3wec | AUI | Cytochrome P450 | / | 0.461 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.460 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.459 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.458 | |
| 4a4w | YFB | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
| 1kb9 | SMA | Cytochrome b | / | 0.457 | |
| 1ezv | SMA | Cytochrome b | / | 0.456 | |
| 2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.456 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.455 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.454 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.453 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.453 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.453 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
| 2ath | 3EA | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 1bq6 | COA | Chalcone synthase 2 | 2.3.1.74 | 0.451 | |
| 2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.451 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.451 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.450 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.450 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.449 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.449 | |
| 4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.449 | |
| 4ly9 | 1YY | Glucokinase regulatory protein | / | 0.449 | |
| 3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.448 | |
| 2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.447 | |
| 3cx5 | SMA | Cytochrome b | / | 0.446 | |
| 3d3e | D3E | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.446 | |
| 4nxv | GDP | Mitochondrial dynamics protein MID51 | / | 0.446 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.445 | |
| 4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 5a27 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
| 1ffu | FAD | Carbon monoxide dehydrogenase medium chain | / | 0.444 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
| 2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.444 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.443 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.443 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.443 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.443 | |
| 3crz | FAD | Ferredoxin--NADP+ reductase | / | 0.442 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 5eox | ADP | Type 4 fimbrial biogenesis protein PilM | / | 0.442 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.441 | |
| 3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.441 | |
| 3sgt | P09 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | / | 0.441 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.441 | |
| 4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 2voj | NAD | Alanine dehydrogenase | 1.4.1.1 | 0.440 | |
| 2zla | VDB | Vitamin D3 receptor | / | 0.440 | |
| 3cmc | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.440 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.440 | |
| 3q8x | UD1 | Toxin zeta | / | 0.440 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.440 | |
| 4okn | NAI | L-lactate dehydrogenase A chain | 1.1.1.27 | 0.440 |